StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences cash

Cash and short-term investments held at the end of each period.

ENDRA Life Sciences's cash was $1.74M at Jun 30, 2026. For fiscal 2025 it was $762.37K, down 76.4% from the year before. Over ten years it grew 44.6% a year on average. The highest annual figure on record is $9.46M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$762.37K-76.4%
FY2024Dec 31, 2024$3.23M+14.0%
FY2023Dec 31, 2023$2.83M-42.0%
FY2022Dec 31, 2022$4.89M-48.3%
FY2021Dec 31, 2021$9.46M+30.9%
FY2020Dec 31, 2020$7.23M+17.1%
FY2019Dec 31, 2019$6.17M-4.6%
FY2018Dec 31, 2018$6.47M+15.5%
FY2017Dec 31, 2017$5.60M+3764.6%
FY2016Dec 31, 2016$144.95K+657.8%
FY2015Dec 31, 2015$19.13K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.74M-3.8%
Q1 FY2026Mar 31, 2026$356.46K-82.7%
Q4 FY2025Dec 31, 2025$762.37K-76.4%
Q3 FY2025Sep 30, 2025$794.04K-83.3%
Q2 FY2025Jun 30, 2025$1.81M-71.7%
Q1 FY2025Mar 31, 2025$2.06M+82.0%
Q4 FY2024Dec 31, 2024$3.23M+14.0%
Q3 FY2024Sep 30, 2024$4.75M+42.3%
Q2 FY2024Jun 30, 2024$6.40M+32.8%
Q1 FY2024Mar 31, 2024$1.13M-51.8%
Q4 FY2023Dec 31, 2023$2.83M-42.0%
Q3 FY2023Sep 30, 2023$3.33M-58.4%
Q2 FY2023Jun 30, 2023$4.82M-57.3%
Q1 FY2023Mar 31, 2023$2.36M-67.0%
Q4 FY2022Dec 31, 2022$4.89M-48.3%
Q3 FY2022Sep 30, 2022$8.02M-32.0%
Q2 FY2022Jun 30, 2022$11.28M-19.7%
Q1 FY2022Mar 31, 2022$7.13M-57.7%
Q4 FY2021Dec 31, 2021$9.46M+30.9%
Q3 FY2021Sep 30, 2021$11.79M+210.9%
Q2 FY2021Jun 30, 2021$14.04M+1776.0%
Q1 FY2021Mar 31, 2021$16.84M+442.8%
Q4 FY2020Dec 31, 2020$7.23M+17.1%
Q3 FY2020Sep 30, 2020$3.79M+66.7%
Q2 FY2020Jun 30, 2020$748.56K-67.0%
Q1 FY2020Mar 31, 2020$3.10M-21.0%
Q4 FY2019Dec 31, 2019$6.17M-4.6%
Q3 FY2019Sep 30, 2019$2.28M+257.1%
Q2 FY2019Jun 30, 2019$2.27M+2.8%
Q1 FY2019Mar 31, 2019$3.93M+24.6%
Q4 FY2018Dec 31, 2018$6.47M+15.5%
Q3 FY2018Sep 30, 2018$637.12K-90.9%
Q2 FY2018Jun 30, 2018$2.21M-70.7%
Q1 FY2018Mar 31, 2018$3.15M+2256.4%
Q4 FY2017Dec 31, 2017$5.60M+3764.6%
Q3 FY2017Sep 30, 2017$6.98M+9136.4%
Q2 FY2017Jun 30, 2017$7.52M–
Q1 FY2017Mar 31, 2017$133.68K–
Q4 FY2016Dec 31, 2016$144.95K–
Q3 FY2016Sep 30, 2016$75.54K–

More ENDRA Life Sciences figures

See a number that looks wrong?